Eric Randolph Bates

Eric Randolph Bates's AcademicInfluence.com Rankings

Eric Randolph Bates

Medical

#2018

World Rank

#2409

Historical Rank

Cardiology

#167

World Rank

#172

Historical Rank

medical Degrees

Eric Randolph Bates

Philosophy

#5925

World Rank

#8860

Historical Rank

Logic

#3133

World Rank

#4249

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Eric Randolph Bates's Degrees

Doctorate Medicine University of California, San Francisco
Masters Public Health University of California, Berkeley

Why Is Eric Randolph Bates Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Eric Randolph Bates's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi (2004) (7144)
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. (1993) (3530)
Optimal medical therapy with or without PCI for stable coronary disease. (2007) (3509)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. (2011) (2418)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. (2011) (2262)
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) (2009) (2012)
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy (2008) (1505)
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008) (1319)
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016) (1234)
Circumferential pulmonary-vein ablation for chronic atrial fibrillation. (2006) (949)
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (927)
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infa (2016) (866)
Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation: A New Drug–Drug Interaction (2003) (744)
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials (2009) (741)
Focused Update of the ACC / AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (2007) (740)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. (2011) (720)
2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention (2013) (682)
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. (2008) (581)
Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy (2006) (574)
Times to Treatment in Transfer Patients Undergoing Primary Percutaneous Coronary Intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 Analysis (2005) (547)
Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance (2004) (541)
ACCF/AHA Expert Conseusus Document (2009) (530)
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. (2001) (481)
Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? (2003) (437)
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016) (396)
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (376)
Expert consensus document American College of Cardiology / European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy (2003) (367)
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. (2001) (353)
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina (1998) (351)
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2021) (336)
The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. (1986) (309)
Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). (2002) (305)
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? (2000) (303)
Analysis of Coronary Angioplasty Practice in the United States With an Insurance‐Claims Data Base (1993) (286)
Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. (1988) (284)
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary (2021) (275)
Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. (2003) (260)
Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States: Implications for Prehospital Triage of Patients With ST-Elevation Myocardial Infarction (2006) (258)
Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies (2008) (258)
Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. (1998) (255)
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial (2000) (252)
ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on carotid stenting. (2007) (236)
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. (1999) (224)
Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms. (1985) (223)
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use (2008) (223)
Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. (1997) (220)
IL-8 is an angiogenic factor in human coronary atherectomy tissue. (2000) (217)
Application of digital techniques to selective coronary arteriography: use of myocardial contrast appearance time to measure coronary flow reserve. (1984) (213)
Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. (2004) (193)
Clopidogrel-drug interactions. (2011) (188)
Operator experience and carotid stenting outcomes in Medicare beneficiaries. (2011) (187)
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. (2012) (184)
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. (2014) (182)
Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction (2008) (182)
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. (1997) (172)
Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. (1986) (168)
ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). (2007) (157)
2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary (2012) (149)
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. (2000) (146)
Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. (1997) (143)
Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterization. (1985) (140)
Mortality Within 24 Hours of Thrombolysis for Myocardial Infarction: The Importance of Early Reperfusion (1994) (139)
Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. (1991) (138)
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). (2005) (136)
Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. (1993) (132)
Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management. (1992) (127)
Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial. (1998) (119)
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. (1987) (117)
Relation Between Hospital Specialization With Primary Percutaneous Coronary Intervention and Clinical Outcomes in ST-Segment Elevation Myocardial Infarction: National Registry of Myocardial Infarction-4 Analysis (2006) (115)
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 Expert Consensus Document on Coronary Computed Tomographic Angiography (2010) (115)
patients (writing committee to revise the 1999 guidelines for the management of of Cardiology/American Heart Association Task Force on practice guidelines myocardial infarction—executive summary: A report of the American College ACC/AHA guidelines for the management of patients with ST-Elevation (2009) (111)
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. (2010) (111)
Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment? (2004) (109)
Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. (1997) (106)
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial (1997) (106)
Racial Differences in Responses to Thrombolytic Therapy With Recombinant Tissue‐Type Plasminogen Activator: Increased Fibrin(ogen)olysis in Blacks (1991) (106)
Comparative study of coronary flow reserve, coronary anatomy and results of radionuclide exercise tests in patients with coronary artery disease. (1986) (104)
Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. (2008) (102)
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy (1991) (100)
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. (1989) (99)
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality. (1989) (98)
Time to treatment in patients with STEMI. (2013) (97)
Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. (2003) (96)
Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction. (1986) (96)
Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function. (1987) (95)
A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. (1991) (89)
Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. (1994) (84)
A randomized controlled trial of information‐giving to patients referred for coronary angiography: effects on outcomes of care (1998) (84)
Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? (2010) (84)
Prognostic implication of troponin I elevation after percutaneous coronary intervention. (2003) (79)
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on Cardiac Catheterization Laboratory Standards (2001) (79)
Criteria for successful coronary angioplasty as assessed by alterations in coronary vasodilatory reserve. (1984) (78)
A Monoclonal Antibody Against the Platelet Glycoprotein IIb/IIIa Receptor Complex Prevents Platelet Aggregation and Thrombosis in a Canine Model of Coronary Angioplasty (1991) (76)
Hormonal responses to cardiac tamponade: inhibition of release of atrial natriuretic factor despite elevation of atrial pressures. (1987) (76)
Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. (1989) (76)
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients. (1996) (76)
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase Results from GUSTO-III (1999) (75)
A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. (1994) (74)
Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease (2018) (74)
Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. (1989) (72)
Relation between coronary artery stenosis assessed by visual, caliper, and computer methods and exercise capacity in patients with single-vessel coronary artery disease. The Veterans Affairs ACME Investigators. (1994) (72)
Emergency Department Bypass for ST-Segment–Elevation Myocardial Infarction Patients Identified With a Prehospital Electrocardiogram: A Report From the American Heart Association Mission Lifeline Program (2013) (71)
Precordial ST segment depression predicts a worse prognosis in inferior infarction despite reperfusion therapy. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. (1990) (71)
Comparative long-term effects of coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty on regional coronary flow reserve. (1985) (70)
A Comparison of Abciximab and Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis of Contemporary Randomized Controlled Trials (2009) (70)
2007 focused update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. (2008) (69)
ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3) (2015) (66)
Rapid hemodynamic improvement after reperfusion during right ventricular infarction. (1995) (64)
Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus. (2007) (64)
Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry. (2015) (61)
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data set. (1999) (60)
Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome. (1988) (59)
Evaluation and treatment of acute myocardial infarction complicating systemic lupus erythematosus. (1992) (59)
Improving Care of STEMI in the United States 2008 to 2012 (2018) (58)
Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis. (1991) (58)
ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting (2007) (57)
Periprocedural myocardial infarction and mortality: causality versus association. (2003) (57)
Revisiting reperfusion therapy in inferior myocardial infarction. (1997) (56)
Nationwide Analysis of Patients With ST-Segment–Elevation Myocardial Infarction Transferred for Primary Percutaneous Intervention: Findings From the American Heart Association Mission: Lifeline Program (2015) (56)
PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. (2016) (56)
Predictors of length of stay after coronary stenting. (2001) (56)
Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy: Observations From the COURAGE Trial (2011) (52)
Predictors of success for coronary angioplasty performed for acute myocardial infarction. (1988) (51)
Effect of angioplasty-induced endothelial denudation compared with medial injury on regional coronary blood flow. (1987) (51)
Demonstration of the "no-reflow" phenomenon by digital coronary arteriography. (1986) (51)
Genetic Causes of Clopidogrel Nonresponsiveness: Which Ones Really Count? (2010) (48)
Effect of percutaneous coronary intervention on quality of life: A consensus statement from the society for cardiovascular angiography and interventions (2013) (47)
Effect of amiodarone on mortality after myocardial infarction (1993) (47)
Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial (2009) (47)
Reperfusion therapy in inferior myocardial infarction. (1988) (46)
Loading, Pretreatment, and Interindividual Variability Issues With Clopidogrel Dosing (2005) (45)
COCATS 4 Task Force 10: Training in Cardiac Catheterization. (2015) (45)
Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. (2009) (44)
Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age. (1989) (44)
Clinical profile of prasugrel, a novel thienopyridine. (2008) (43)
Effect of Vasopressors on Atrial Natriuretic Factor and Hemodynamic Function in Humans (1988) (41)
The Problem of Persistent Platelet Activation in Acute Coronary Syndromes and Following Percutaneous Coronary Intervention (2008) (40)
Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). (2013) (40)
Lack of progress in cardiogenic shock: lessons from the GUSTO trials (2000) (40)
Assessing the Current Role of Platelet Function Testing (2008) (40)
Treatment of recurrent ischemia after thrombolysis and successful reperfusion for acute myocardial infarction: effect on in-hospital mortality and left ventricular function. (1991) (39)
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? (2014) (39)
Commentary: the role of percutaneous coronary intervention in ST-segment-elevation myocardial infarction. (2008) (38)
Treatment Options in Severe Aortic Stenosis (2011) (37)
Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations (2012) (37)
An analysis of the cause of early mortality after administration of thrombolytic therapy (1993) (37)
Management of Cardiogenic Shock Attributable to Acute Myocardial Infarction in the Reperfusion Era (2005) (37)
Expert Consensus Document Accf/acr/aha/nasci/scmr 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance a Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents Writing Committee Members Expert Consensus Document Table of Contents Hundley Et Al (2010) (36)
Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventions. (1998) (34)
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group. (2012) (34)
Comparison of artificial neural networks with logistic regression in prediction of in-hospital death after percutaneous transluminal coronary angioplasty. (2000) (34)
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. (1999) (32)
Effect of platelet inhibition with cangrelor during PCI on ischemic events (2013) (32)
A comparison of 35 mm cine film and digital radiographic image recording: implications for quantitative coronary arteriography. Film vs. digital coronary quantification. (1988) (32)
Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). (1995) (31)
DIGITAL RADIOGRAPHIC CORONARY ARTERY QUANTIFICATION. (1985) (31)
Prevention of Rethrombosis After Coronary Thrombolysis in a Chronic Canine Model. I. Adjunctive Therapy with Monoclonal Antibody 7E3 F(ab')2 Fragment (1994) (31)
Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial. (2013) (31)
Lack of progress in cardiogenic shock: lessons from the GUSTO trials. (2000) (30)
Usefulness of translesional pressure gradient and pharmacological provocation for the assessment of intermediate renal artery disease (2006) (30)
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy. (2011) (30)
2016 ACC Lifelong Learning Competencies for General Cardiologists: A Report of the ACC Competency Management Committee. (2016) (29)
Primary percutaneous coronary intervention expansion to hospitals without on-site cardiac surgery in Michigan: a geographic information systems analysis. (2008) (29)
Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock--a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry. (2006) (29)
Emergent percutaneous cardiopulmonary bypass in patients having cardiovascular collapse in the cardiac catheterization laboratory. (1994) (28)
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. (2016) (28)
Acute ST-elevation myocardial infarction (2012) (28)
Coronary stent implantation in acute myocardial infarction. (1999) (28)
Choice of Reperfusion Strategy at Hospitals With Primary Percutaneous Coronary Intervention: A National Registry of Myocardial Infarction Analysis (2009) (27)
Sustained inhibition of the vessel wall‐platelet interaction after deep coronary artery injury by temporary inhibition of the platelet glycoprotein llb/llla receptor (1992) (26)
Incidence and predictors of early recurrent ischemia after successful percutaneous transluminal coronary angioplasty for acute myocardial infarction. (1989) (26)
Early ambulation following 6 French diagnostic left heart catheterization: a prospective randomized trial. (1997) (26)
Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome (2014) (25)
Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D). (2009) (25)
Endoluminal stenting for unprotected left main stenosis in Takayasu's arteritis. (1997) (25)
Direct thrombin inhibitors in cardiac disease (2007) (24)
Controversies in Antiplatelet Therapy for Patients With Cardiovascular Disease (2005) (24)
Reperfusion Therapy Reduces the Risk of Myocardial Rupture Complicating ST‐Elevation Myocardial Infarction (2014) (23)
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study Group. (1991) (23)
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability. (2002) (23)
The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock. (1998) (23)
The enduring value of Killip classification. (1999) (22)
Temporal Trends in the Use of Drug‐eluting Stents for Approved and Off‐label Indications: A Longitudinal Analysis of a Large Multicenter Percutaneous Coronary Intervention Registry (2010) (22)
Reperfusion Therapy for Acute Myocardial Infarction (2008) (22)
Quantitative regional curvature analysis: a prospective evaluation of ventricular shape and wall motion measurements. (1988) (22)
How can we optimize the processes of care for acute coronary syndromes to improve outcomes? (2014) (21)
Coronary flow reserve measured during cardiac catheterization. (1984) (21)
Emergency extracorporeal membrane oxygenation (ECMO)‐supported percutaneous coronary interventions in the fibrillating heart (1999) (21)
Effectiveness of percutaneous coronary intervention in patients with silent myocardial ischemia (post hoc analysis of the COURAGE trial). (2012) (21)
2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion). (2015) (20)
False activation of the cardiac catheterization laboratory for primary PCI. (2013) (19)
Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. (1996) (18)
Direct Transfer From the Referring Hospitals to the Catheterization Laboratory to Minimize Reperfusion Delays for Primary Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry (2015) (18)
Coronary angioplasty as therapy for acute myocardial infarction: University of Michigan experience. (1987) (18)
Oral hydralazine therapy for acute pulmonary embolism and low output state. (1981) (18)
Cardiogenic shock complicating myocardial infarction. (2007) (17)
Drug-drug interactions involving antiplatelet agents. (2003) (17)
Update on primary PCI for patients with STEMI. (2017) (17)
Successful coronary angioplasty in two patients with cardiogenic shock using the Nimbus Hemopump support device. (1990) (16)
Prevention of Rethrombosis After Coronary Thrombolysis in a Chronic Canine Model. II. Adjunctive Therapy with r‐Hirudin (1994) (16)
Directional atherectomy of coronary and saphenous vein graft ostial stenoses. (1995) (16)
Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral and Structural Heart Disease. (2010) (16)
Broken bodies, broken hearts? Limitations of the trauma system as a model for regionalizing care for ST-elevation myocardial infarction in the United States. (2006) (15)
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial. (2005) (15)
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1997) (15)
Reversibility of coronary collaterals and alteration in regional coronary flow reserve after successful angioplasty. (1984) (15)
2012 American college of cardiology foundation/society for cardiovascular angiography and interventions expert consensus document on cardiac catheterization laboratory standards update: American college of cardiology foundation task force on expert consensus documents society of thoracic surgeons so (2012) (15)
Role of Intravenous β-Blockers in the Treatment of ST-Elevation Myocardial Infarction: Of Mice (Dogs, Pigs) and Men (2007) (14)
ST-Segment–Elevation Myocardial Infarction Care and COVID-19 (2020) (14)
Acute myocardial infarction in two adolescent males (1998) (14)
Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain (2007) (13)
Use of Intraaortic Balloon Counterpulsation in Patients Presenting With Cardiogenic Shock: Observations From the GUSTO-I Study fn1fn1This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, (1997) (13)
Evaluation of patients with suspected coronary artery disease. (2010) (13)
American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document on cardiac catheterization laboratory standards: Summary of a report of the American College of Cardiology Task Force on clinical expert consensus documents (2001) (13)
Pulmonary extraction of immunoreactive atrial natriuretic factor in dogs. (1989) (12)
Investigating the Mechanisms of Hyporesponse to Antiplatelet Approaches (2008) (12)
Comparative Effectiveness and Safety of a Catheterization Laboratory–Only Eptifibatide Dosing Strategy in Patients Undergoing Percutaneous Coronary Intervention (2015) (11)
Ischemic complications after percutaneous transluminal coronary angioplasty. (2000) (11)
Clinical trial results with hirudin and bivalirudin for acute coronary artery syndromes. (1997) (11)
Taking the Reins on Systems of Care for ST-Segment–Elevation Myocardial Infarction Patients: A Report From the American Heart Association Mission Lifeline Program (2018) (11)
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial. (2005) (11)
Reducing costs and improving outcomes of percutaneous coronary interventions. (2003) (11)
Antiplatelet Strategies: Evaluating Their Current Role in the Setting of Acute Coronary Syndromes (2008) (11)
Clinical significance of the atorvastatin-clopidogrel drug-drug interaction. (2004) (11)
The chronic coronary flow reserve provided by saphenous vein bypass grafts as determined by digital coronary radiography. (1984) (10)
Antiplatelet Therapy and Platelet Function Testing (2008) (10)
Bivalirudin: an anticoagulant option for percutaneous coronary intervention (2004) (10)
Sustained saline-induced secretion of atrial natriuretic hormone is not maintained by atrial stretch. (1989) (10)
Value of exercise radionuclide ventriculography and thallium-201 scintigraphy in evaluating successful coronary angioplasty: comparison with coronary flow reserve, translesional gradient and percent diameter stenosis. (1987) (10)
Early reperfusion therapy improves left ventricular function after acute inferior myocardial infarction associated with right coronary artery disease. (1987) (9)
Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI). (2007) (9)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (9)
Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO. (1992) (9)
It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy Debates. (2017) (8)
Competitive bidding for interventional cardiology supplies: lessons learned during round 2. (2002) (8)
The Contemporary Use of Angiography and Revascularization Among Patients With Non–ST‐Segment Elevation Myocardial Infarction in the United States Compared With South Korea (2015) (8)
Subacute bilateral coronary ostial stenoses following cardiac catheterization and PTCA. (1991) (8)
Evolution from fibrinolytic therapy to a fibrinolytic strategy for patients with ST-segment-elevation myocardial infarction. (2014) (8)
Letter by Tsai et al regarding article, "correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and Paclitaxel-eluting stents". (2006) (7)
The COVID-19 Pandemic and Cardiovascular Complications (2020) (7)
Chapter 10 – ST-Segment Elevation Myocardial Infarction (2012) (7)
Aspirating and filtering atherothrombotic debris during percutaneous coronary intervention. (2008) (7)
Raising high-density lipoprotein cholesterol and lowering low-density lipoprotein cholesterol as adjunctive therapy to coronary artery revascularization. (2000) (7)
Quantitative assessment of global and regional left ventricular function with low-contrast dose digital subtraction ventriculography. (1985) (7)
Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes. (2020) (7)
Mission: Lifeline STEMI networks geospatial information systems (GIS) maps. (2013) (7)
STEMI Care and COVID-19: The Value Proposition of Pharmacoinvasive Therapy. (2020) (7)
Echocardiographic diagnosis of flail anterior leaflet in tricuspid endocarditis. (1983) (7)
Increased risk for abrupt closure during elective PTCA in the post-myocardial infarction period (1991) (7)
Update on the American Board of Internal Medicine Maintenance of Certification Program: a report of the American College of Cardiology's Educational Quality Review Board. (2014) (7)
Association Task Force on Practice Guidelines A Report of the American College of Cardiology Foundation/American Heart Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous With ST-Elevation Myocardial Infarction (2009) (7)
Anticoagulant therapy in acute coronary syndromes. (2007) (6)
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (6)
Balancing the Benefits, Risks, and Costs of Chronic Total Occlusion Percutaneous Coronary Intervention. (2019) (6)
Current role of antithrombotic agents in the treatment of acute coronary syndromes. (2004) (6)
Clopidogrel nonresponders discovered during point-of-care platelet aggregation testing (2003) (6)
Cardiac applications of digital subtraction angiography (2005) (6)
Requiem by a Member of the Inaugural Generation of Interventional Cardiologists (2019) (6)
The effect of high-risk ST elevation myocardial infarction transfer patients on risk-adjusted in-hospital mortality: A report from the American Heart Association Mission: Lifeline program. (2016) (6)
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. (2016) (6)
Balancing the Evidence Base on Coronary Stents. (2016) (6)
Guidelines College of Cardiology/American Heart Association Task Force on Practice Patients With ST-Elevation Myocardial Infarction. A report of the American 2007 Focused update of the ACC/AHA 2004 Guidelines for the Management of (2007) (5)
Limiting Infarct Size in ST-Segment Myocardial Infarction: The Holy Grail of Reperfusion Therapy. (2015) (5)
Expert Consensus Document Accf/acr/aha/nasci/saip/scai/scct 2010 Expert Consensus Document on Coronary Computed Tomographic Angiography a Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents Writing Committee Members Expert Consensus Document Table of Cont (5)
Is computer interpretation of the exercise electrocardiogram a reasonable surrogate for visual reading? (1997) (5)
Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes (2001) (5)
Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion. (1999) (5)
Structural Heart Disease Interventions (2012) (5)
Platelet glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. (1998) (5)
Quality Improvement in Management of Acute Coronary Syndrome: Continuing Medical Education and Peer Coaching Improve Antiplatelet Medication Adherence and Reduce Hospital Readmissions (2017) (5)
Angioplasty versus thrombolytics for patients presenting with congestive heart failure; GUSTO IIb substudy findings (1998) (5)
Bleeding Avoidance Strategies, Performance Measures, and the Emperor's New Clothes. (2016) (5)
Value of Registries in ST‐Segment–Elevation Myocardial Infarction Care in Both the Pre–Coronavirus Disease 2019 and the Coronavirus Disease 2019 Eras (2020) (5)
Evaluation of a BED-SIDE platelet function assay: performance and clinical utility. (2002) (5)
Association of race with complications and prognosis following acute coronary syndromes. (2004) (5)
Coronary artery steal: demonstration by digital coronary radiography. (1985) (4)
790-4 The Prognostic Importance of Anterior ST-Segment Depression in Inferior Myocardial Infarctions: Results in 16,185 Patients (1995) (4)
Relation Between Coronary Artery Stenosis Assessed by Visual, Caliper, and Computer Methods and Exercise Capacit in Patients With Single-Vessel Coronary Artery Disease (2005) (4)
Timeliness of treatment is more important than choice of reperfusion therapy (2010) (4)
Expanding indications for thrombolytic therapy in acute myocardial infarction. (1993) (4)
Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus (2013) (4)
Cardiogenic shock. (1995) (4)
Coronary artery dissection caused by exit of the guidewire through the distal perfusion sidehole of an auto-perfusion angioplasty balloon catheter. (1994) (4)
Thrombolytic therapy for acute myocardial infarction. (1989) (4)
Percutaneous atherectomy catheters. (1988) (4)
Clinical problem-solving. A change of heart. (2009) (4)
Saphenous vein bypass graft disease (1998) (4)
Antiplatelet Therapy in Patients with Coronary Disease and Type 2 Diabetes. (2019) (4)
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb. (2008) (4)
DAILY TEMPERATURE FLUCTUATIONS AND MYOCARDIAL INFARCTION: IMPLICATIONS OF GLOBAL WARMING ON CARDIAC HEALTH (2018) (3)
Clinical Considerations with the Use of Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention (2008) (3)
The Editor's Roundtable: arterial thrombosis and acute coronary syndromes. (2007) (3)
ACCF COMPLEMENTARY MEDICINE EXPERT CONSENSUS DOCUMENT (2018) (3)
Antiplatelet Therapy and Platelet Function Testing (2008) (3)
Percutaneous Coronary Intervention for Cardiogenic Shock (2009) (3)
Noninvasive assessment of patients undergoing percutaneous intervention in myocardial infarction. (2010) (3)
Early hospital discharge in the myocardial reperfusion era. (1989) (3)
New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction (2007) (3)
Cardiovascular Catheterization and Intervention : A Textbook of Coronary, Peripheral, and Structural Heart Disease, Second Edition (2017) (3)
Evidence of abnormal vasodilator reserve in coronary spasm. (1986) (3)
Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease. (2020) (3)
Pre-hospital Transport Times and Outcomes After Different Reperfusion Strategies for ST-Elevation Myocardial Infarction. (2019) (3)
Angiography and Interventions Association Task Force on Practice Guidelines and the Society for Cardiovascular Summary : A Report of the American College of Cardiology Foundation/American Heart 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive (2012) (3)
Survival for 88 Years with Sinus Venosus Atrial Septal Defect (1985) (3)
2009 Focused Updates: STEMI and PCI Guidelines (2009) (2)
Symptomatic carotid artery stenosis: what is the preferred treatment? (2011) (2)
PRIMARY ANGIOPLASTY IS THE OPTIMAL APPROACH TO EARLY REPERFUSION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (1995) (2)
the Society for Cardiovascular Angiography and Interventions Foundation/American Heart Association Task Force on Practice Guidelines and Executive Summary : A Report of the American College of Cardiology 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: (2011) (2)
Challenging coronary artery revascularization paradigms. (2007) (2)
Individual chest pain characteristics had low accuracy for detecting acute MI in both men and women (2014) (2)
Patients With ST-Elevation Myocardial Infarction : 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of (2012) (2)
Abstract 2449: Clinical Outcomes in Women with Stable Coronary Artery Disease Randomized to Optimal Medical Therapy With or Without PCI: Pre-Specified Subset Analysis of the COURAGE Trial (2007) (2)
The Misinterpretation of Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Ischemic Heart Disease. (2018) (2)
Is Early Infarct Artery Patency the Goal or Not (1992) (2)
Review: In patients with chest pain, risk scores better predict high risk for ACS than individual risk factors (2016) (2)
Extended Dual Antiplatelet Therapy in Patients With Prior Myocardial Infarction. (2016) (2)
Treatment of Acute Myocardial Infarction: A Cardiologist's Perspective (1992) (2)
1106-181 Clopidogrel is an inducer and a potent reversible inhibitor of cytochrome P450 3A4 in vitro (2004) (2)
The effect of drugs which are known inducers and inhibitors of human cytochrome P450 3A on the platelet inhibitory activity of clopidogrel (2002) (2)
Atherectomy or angioplasty for coronary artery disease (1994) (2)
In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI (2017) (2)
Review: PTCA reduces adverse cardiac outcomes and death better than thrombolytics after myocardial infarction (2003) (2)
IMPACT OF PRETREATMENT ISCHEMIA ON THERAPEUTIC RISK REDUCTION AND LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE ANGINA: RESULTS FROM COURAGE TRIAL (2010) (2)
Cardiovascular Angiography and Interventions Association Task Force on Practice Guidelines and the Society for Report of the American College of Cardiology Foundation/American Heart 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A (2012) (2)
Dissolution of angiographically detected intracoronary thrombus for unstable angina pectoris after aspirin therapy. (1987) (2)
Digital subtraction angiographic assessment of the coronary arteries and coronary flow reserve (2005) (2)
Comprehensive electrocardiogram‐to‐device time for primary percutaneous coronary intervention in ST‐segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline program (2018) (2)
Updated European guidelines on the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2009) (2)
Achieving Aspirational Goals in Providing Primary Percutaneous Coronary Intervention Care. (2019) (2)
Review: aspirin reduces the incidence of coronary artery disease in people at risk (2001) (2)
Infusion of Vasopressors Increases Plasma irANH Levels in Normal Men (1986) (2)
1001-25 Combined Intralesional Tissue Plasminogen Activator and Intracoronary Heparin in Patients with Unstable Angina and Coronary Thrombus Undergoing PTCA (1995) (2)
Long Term Results from the Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO-I) Trial: Sustained Benefit of Fibrin-Specific Therapy (1999) (2)
Outcomes of angioplasty vs thrombolysis by hospital angioplasty volume. (2001) (2)
1001-25 Combined Intralesional Tissue Plasminogen Activator and Intracoronary Heparin in Patients with Unstable Angina and Coronary Thrombus Undergoing PTCA (1995) (2)
Percutaneous coronary intervention strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease (2017) (2)
Treatment options for STEMI patients who present to hospitals without PCI capability (2009) (1)
Review: Limited evidence suggests that statins are safe in patients with liver disease (2008) (1)
Review: glycoprotein IIb/IIIa inhibitors reduced death or MI in acute coronary syndromes not routinely scheduled for revascularization. (2002) (1)
Prehospital thrombolytic therapy reduced mortality in acute MI (1996) (1)
In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes (2021) (1)
Adding colchicine to standard therapy after cardiac surgery reduced risk for the postpericardiotomy syndrome (2011) (1)
Liposomal PGE-1 adjunctive treatment for acute myocardial infarction: final results of the LIFT pilot trial (1998) (1)
Primary percutaneous coronary intervention with drug-eluting stents: another chapter in the stent controversy. (2008) (1)
In left main CAD, PCI with everolimus-eluting stents was noninferior to CABG for death, MI, or stroke at 3 years (2017) (1)
Acute transmural myocardial infarction (2000) (1)
Acute Myocardial Infarction Hospital Outcomes in Patients Presenting With Congestive Heart Failure Complicating Acute Myocardial Infarction (2016) (1)
Weighing the risks of target vessel revascularization versus very late stent thrombosis in primary percutaneous coronary intervention. (2012) (1)
THE ASSOCIATION BETWEEN DRIVE TIME AND REPERFUSION THERAPY USE AMONG STEMI PATIENTS TRANSFERRED FROM A NON-PRIMARY PCI HOSPITAL: A REPORT FROM THE MISSION: LIFELINE PROGRAM (2013) (1)
The editorialist replies (2016) (1)
Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction. (2008) (1)
ACCF Complementary Medicine Expert Consensus Document — Online Appendices Integrating Complementary Medicine Into Cardiovascular Medicine (2005) (1)
Review: glycoprotein IIb/IIIa inhibitors reduced death or myocardial infarction in acute coronary syndromes not routinely scheduled for revascularisation (2002) (1)
FIBRINOLYTIC THERAPY USE AMONG STEMI PATIENTS TRANSFERRED TO A PRIMARY PCI HOSPITAL IN THE UNITED STATES: A REPORT FROM THE MISSION: LIFELINE PROGRAM (2013) (1)
715-1 Predictors of Mortality in Cardiogenic Shock: The GUSTO Experience (1995) (1)
A Change of Heart (2017) (1)
Coronary angioplasty in cardiogenic shock. (1999) (1)
Abstract 4502: Drug-Eluting Stents Reduce Reinfarction Risk in Patients With Acute Myocardial Infarction: A Network Meta-Analysis (2009) (1)
Misguided Use of Multivariable Analysis to Study Primary Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft. (2016) (1)
Response to Letter Regarding Article, "Evolution From Fibrinolytic Therapy to a Fibrinolytic Strategy for Patients With ST-Segment-Elevation Myocardial Infarction". (2015) (1)
Effect of antiplatelet drugs and heparin on reactive hyperemia after coronary angioplasty in a canine model (1990) (1)
Determinants of Left Ventricular Functional Recovery After Thrombolytic Therapy and/or Immediate Coronary Angioplasty in Acute Myocardial Infarction (1988) (1)
Left main coronary disease: evolving management concepts. (2022) (1)
Bates Treatment Options in Severe Aortic Stenosis 357 (2011) (1)
Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes. (2003) (1)
Review: invasive management after unstable angina or non-ST-segment elevation MI does not reduce risk for death or MI. (2005) (1)
Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. (2013) (1)
Therelationship between plasmalevels of immunoreactive atrial natriuretic hormoneand hemodynamic function inman (1986) (1)
Review: In CAD, CABG reduced 5-year mortality more than PCI in multivessel but not left main disease (2018) (1)
Review: low-molecular-weight heparin is more effective than unfractionated heparin for preventing reinfarction in STEMI. (2006) (0)
Tirofiban plus heparin was more effective than heparin alone for unstable angina and non-Q-wave MI (1998) (0)
Review: In patients with previous MI, long-term DAPT reduces CV events and increases major bleeding (2016) (0)
Contributors (2019) (0)
Treatment Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Is Staged PCI Truly the Best Option? (2017) (0)
In STEMI, manual thrombectomy before PCI did not reduce CV-related outcomes but increased stroke (2015) (0)
Did “Pistol” Pete Maravich Die From Congenital Coronary Artery Disease or Acquired Myocardial Disease?∗ (2020) (0)
Review: routine invasive management after unstable angina or non-ST-segment elevation MI reduces risk for death or MI. (2005) (0)
Causes of delay and associated mortality in patients transferred with STEMI (2012) (0)
Review: percutaneous coronary angioplasty is associated with less angina but more coronary artery bypass grafting in patients with non-acute coronary artery disease than is medical treatment (2001) (0)
on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions the American College of Cardiology Foundation/American Heart Association Task Force 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A Report of (2012) (0)
Late thrombolysis in acute myocardial infarction (1994) (0)
Late thrombolysis did not improve survival in suspected acute myocardial infarction (1994) (0)
Influence of a critical pathway to maximize same day sheath pulling on an interventional cardiology service: Implications for length of stay and complications (1996) (0)
At-home thrombolysis reduced all-cause mortality and morbidity in patients with acute myocardial infarction (1993) (0)
The Role of Revascularisation in Patients Undergoing Non-cardiac Surgery (2010) (0)
Anatomical and functional testing did not differ for reducing CV events in suspected obstructive CAD (2015) (0)
Erratum: Update on the American Board of Internal Medicine Maintenance of Certification Program: A Report of the American College of Cardiologys Educational Quality Review Board (Journal of the American College of Cardiology (2014) 63 (92-100)) (2014) (0)
Interventional cardiology: Antithrombotic drug and stent choices in primary PCI (2011) (0)
ST-Elevation Myocardial Infarction (2018) (0)
Abstract 13789: A New, Comprehensive, Hospital-Level Time-to-Treatment Metric for Primary Percutaneous Coronary Intervention: A Report From the AHA Mission: Lifeline Program (2014) (0)
Bivalirudin reduces ischemic complications and bleeding after angioplasty for unstable angina (2002) (0)
Coronary angioplasty and bypass surgery for coronary artery disease had similar rates of death and nonfatal MI at 2.5 years (1993) (0)
Iconography : Coronary stent implantation in acute myocardial infarction (2011) (0)
Reperfusion strategies for congestive heart failure or cardiogenic shock (1992) (0)
Low-dose amiodarone led to fewer cardiac deaths and serious arrhythmics in patients surviving myocardial infarction who had contraindications to β-blockers (1993) (0)
Abstract 11056: Hospitals Accepting Greater Proportions of High Risk Transfer-In STEMI Patients Do Not Have Higher Risk-Adjusted Hospital Mortality: A Report From the AHA Mission: Lifeline Program (2014) (0)
Transport of the Patient with Cardiogenic Shock (2002) (0)
Early revascularization improved long-term survival after myocardial infarction with cardiogenic shock. (2006) (0)
Streptokinase, Alteplase, Reteplase, or Tenecteplase (2009) (0)
Reply (2020) (0)
Review: platelet glycoprotein IIb/IIIa blockers for PCI or acute coronary syndromes reduce death and MI but increase bleeding. (2002) (0)
PTCA and CABG had similar long-term mortality and myocardial infarction rates (1999) (0)
COVID-19 STEMI 2020 (2020) (0)
PERIPHERAL DIAGNOSTIC CATHETERS (2010) (0)
REPORTS ON THERAPY A Randomized Placebo-Controlled Trial of Combined Early Intravenous Captopril and Recombinant Tissue-Type Plasminogen Activator Therapy in Acute Myocardial Infarction (2016) (0)
Perioperative Myocardial Infarction: A Report and Discussion of Risk, Diagnosis, and Management - Master Class: Cardiovascular Medicine (2019) (0)
Analysis ofCoronary Angioplasty Practice inthe United States Withan Insurance-Claims DataBase (1993) (0)
Review: In AF, direct oral anticoagulants reduce all-cause and vascular mortality compared with warfarin (2017) (0)
DRIVING TIME TO NEAREST PRIMARY PERCUTANEOUS CORONARY INTERVENTION CENTER AND CHOICE OF REPERFUSION THERAPY FOR ST-ELEVATION MYOCARDIAL INFARCTION (2016) (0)
Both invasive and optimized medical therapies improved quality of life in angina but invasive therapy had fewer major adverse cardiac events. (2003) (0)
A NEW RISK PREDICTION TOOL TO ASSESS LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE (SIHD): THE “COURAGE RISK SCORE” (2011) (0)
Association Mission : Lifeline Program Identified With a Prehospital Electrocardiogram : A Report From the American Heart Elevation Myocardial Infarction Patients − Emergency Department Bypass for ST-Segment (2013) (0)
Enoxaparin was more effective than unfractionated heparin in STEMI, regardless of type of fibrinolytic agent used. (2007) (0)
Primary angioplasty had lower long-term mortality than did streptokinase in acute myocardial infarction (2000) (0)
Accelerated care with early discharge after PTCA was safe and cost-effective (1998) (0)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (0)
ACC/AHA Guidelines Managing patients with ST-elevation myocardial infarction. (2008) (0)
Drug-eluting stents increased risk for late cardiac death or myocardial infarction more than bare-metal stents. (2007) (0)
1066-197 Catheter sequence rather than catheter shape determines the frequency of cerebral microemboli during cardiac catheterization (2004) (0)
Review: Aspirin reduces the incidence of coronary artery disease in persons at risk (2001) (0)
Carotid and vertebral artery interventions (2010) (0)
Abstract 10899: Direct Cath Lab Access Reduced Reperfusion Delays and Mortality for Transferred-in STEMI Patients: Insights From Mission: Lifeline (2013) (0)
Thrombolytic Therapy for Acute Myocardial Intarction (2017) (0)
At-home thrombolysis by general practitioners (1992) (0)
P885Cardiovascular events in patients with suspected ST-elevation myocardial infarction and no obstructive coronary artery disease (2019) (0)
Atherectomy led to better postprocedural luminal dimensions but was similar to angioplasty for 6-month outcomes in left anterior descending coronary arteries (1994) (0)
Is CABG Indicated in Patients With Ischemic Cardiomyopathy? (2022) (0)
Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent angina (2020) (0)
Stent-Centric View of Stable Ischemic Heart Disease. (2020) (0)
Foundation/American Heart Association Task Force on Practice Guidelines Update): A Report of the American College of Cardiology Coronary Intervention (Updating the 2005 Guideline and 2007 Focused 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous With ST-Elevation Myocardial Infarction (2009) (0)
Abstract 12192: Improving Care of ST Segment Elevation Myocardial Infarction in the United States 2008 to 2012: A Report From Mission: Lifeline (2013) (0)
Single-Vessel Coronary Artery Disease (2005) (0)
Cardiovascular Therapies Beyond the Randomized Clinical Trial : The Role of Effectiveness Studies in Evaluating (2013) (0)
ACP Journal Club. Review: Sgarbossa scores > or = 3 have low sensitivity and high specificity for predicting MI in left bundle branch block. (2009) (0)
My stent is better than your stent...Or is it? (2011) (0)
The Role of Intravascular Imaging in Coronary Thrombosis Assessment and Management (2021) (0)
The ASCERT trial: Comparing revascularization strategies (2012) (0)
Ticagrelor was more effective than clopidogrel, with no increase in major bleeding in acute coronary syndromes (2009) (0)
Review: drug-eluting stents for coronary artery disease do not reduce mortality more than bare-metal stents. (2007) (0)
Infusion Fibrinolytic Therapy (2008) (0)
An early invasive strategy reduced death or MI better than a conservative strategy in unstable angina and non-STEMI at advanced age. (2005) (0)
Tirofiban plus heparin was more effective than heparin alone for unstable angina and non–Q-wave MI (1998) (0)
Guided early deescalation of antiplatelet treatment was noninferior to usual prasugrel care in PCI-treated ACS (2017) (0)
Abstract 13231: Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-Hospital ST-Segment Elevation: Findings from the ACTION Registry(R)-GWTG™ (2012) (0)
Streptokinase for inferior myocardial infarction. (1991) (0)
Review: limited evidence suggests that statins are safe in patients with liver disease (2008) (0)
In HFpEF, adding empagliflozin to usual care reduced a composite of CV death or HF hospitalization at a median 26 mo (2022) (0)
Other Drug Interactions with Clopidogrel (2014) (0)
Benefit-risk trade-off was found for stent vs balloon coronary angioplasty (1995) (0)
PREVALENCE AND CLINICAL SIGNIFICANCE OF RECURRENT AND UNREMITTING ANGINA WITH PERCUTANEOUS INTERVENTION VERSUS OPTIMAL MEDICAL THERAPY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE: A POST HOC ANALYSIS OF THE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION AND AGGRESSIVE DRUG EVALUATION TRIAL (2013) (0)
Abstract 16865: Long-Term Clinical Outcomes of Patients with Type 4a Myocardial Infarction Following Elective PCI for Stable Ischemic Heart Disease (SIHD): Post Hoc Analysis of the COURAGE Trial (2012) (0)
Myocardial infarction: a cumulative meta-analysis (1992) (0)
Postmyocardial Infarction Cardiogenic Shock (2019) (0)
A COMPARISON OF CLINICAL OUTCOMES IN THE BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION IN TYPE-2 DIABETES MELLITUS (BARI 2D) BY TYPE OF STENT IMPLANTATION (2010) (0)
Bypass surgery and angioplasty were comparable for preventing ischemic outcomes (1995) (0)
THE CONTEMPORARY USE OF ANGIOGRAPHY AND REVASCULARIZATION AMONG PATIENTS WITH NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION IN THE UNITED STATES VERSUS SOUTH KOREA (2014) (0)
Drugs in Sport: The Doping of Athletes (1972) (0)
Response to letter regarding article, "Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline Program". (2014) (0)
and left Ventkular Function -After Intravenouk Thrombolysis for Acute Myocardial Infarction (1994) (0)
Thrombolytic therapy for acute myocardial infarction: By George J. Taylor, Blackwell Scientific Publications, Cambridge (1992) 240 pages, illustrated, $24.95 ISBN: 9‐86542‐200‐1 (1994) (0)
EFFECT OF AN ONLINE CONTINUING MEDICAL EDUCATION AND CLINICIAN COACHING QUALITY IMPROVEMENT INITIATIVE ON ANTIPLATELET MEDICATION ADHERENCE AND HOSPITAL READMISSIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME (2017) (0)
Primary Prevention of Coronary Artery Disease (2020) (0)
In myocardial injury after noncardiac surgery, dabigatran reduced vascular events without increasing major bleeding (2018) (0)
Optimizing Therapy for Acute Coronary Syndrome (2015) (0)
Discrepancies Between IVUS and Angiography (2010) (0)
Review: After coronary DES placement, 6 mo and 1 y of dual-antiplatelet therapy do not differ for cardiac events (2015) (0)
The “Evolving” Role of Intravascular Imaging in Myocardial Infarction With Nonobstructive Coronary Arteries (2022) (0)
Antiplatelet therapy was better than anticoagulant therapy after coronary stenting (1997) (0)
The role of the electrocardiogram as a prognostic tool in ST-segment elevation myocardial infarction. (2010) (0)
CORONARY PERFORATIONS Introduction (2010) (0)
In suspected MI without ST elevation, a risk tool including hs-cTnI or hs-cTnT predicted diagnosis and 30-d outcomes (2019) (0)
DIGITAL RADIOGRAPHIC TECHNIQUE FOR VISUALIZATION AND QUANTITATION OF REGIONAL MYOCARDIAL PERFUSION. (1983) (0)
on a National Heart, Lung and Blood Institute Working Group Guided Antithrombotic Therapy: Current Status and Future Research Direction: Report (2014) (0)
Intravenous beta-blockers in patients with ST-elevation myocardial infarction treated with primary PCI. (2017) (0)
Angioplasty at an invasive-treatment center reduced mortality compared with first-contact thrombolysis (2004) (0)
Abstract 12612: Characteristics of Best Practice Primary PCI Timing for STEMI Transfer Patients: Findings From the AHA Mission: Lifeline Program® (2014) (0)
Anomalous Coronary Arteries (2010) (0)
Review: After coronary DES placement, shorter vs longer dual- antiplatelet therapy reduces mortality (2015) (0)
Tissue plasminogen activator therapy in the community hospital (1988) (0)
Examination of the Neck Veins. (2021) (0)
Peripheral arterial angiography (2010) (0)
Abstract 168: Effectiveness of Case-Based Education on Clinical Decision-Making in ACS (2014) (0)
Measurement of Cardiac Output (2010) (0)
Abstract 2868: Sex, Clinical Symptoms and Angiographic Findings at Baseline in BARI 2D (2007) (0)
In CAD with LV dysfunction, adding CABG to medical therapy reduced all-cause and CV mortality at 10 y (2016) (0)
coronary angioplasty mortality on an independent data set Validation of risk adjustment models for in-hospital percutaneous transluminal (2011) (0)
Digital radiographic assessment of coronary angioplasty and bypass graft revascularization results (1988) (0)
Recognition and Management of Complications in Cutting-Edge Contemporary Care (2022) (0)
Abstract 18115: Are State Policies to Permit Pre-hospital Bypass Associated With Better Treatment Patterns Among Patients With ST-Elevation Myocardial Infarction? A Report From AHA's Mission: Lifeline Program (2015) (0)
Large-Scale CAS Registries (2010) (0)
After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placebo (2019) (0)
Review: In coronary artery disease, PCI reduces 30-day and 5-year risk for stroke compared with CABG (2018) (0)
Fibrinolysis for ST Elevation Myocardial Infarction: First and Second Generation Agents (2004) (0)
In stable coronary disease with moderate or severe ischemia, initial invasive therapy plus medical therapy did not improve CV outcomes at 3 years (2020) (0)
Ventricular Septal Rupture (2010) (0)
Drug-eluting stents: Weighing the pros and cons of this therapy and its alternatives (2008) (0)
ANGIOGRAPHIC TECHNIQUE Arterial Access (2010) (0)
Multivessel vs. culprit-vessel-only PCI in patients with acute myocardial infarction (2015) (0)
Angioplasty at an invasive treatment centre reduced mortality compared with first contact thrombolysis (2004) (0)
CHAPTER 17 – Cardiogenic Shock (2010) (0)
Review: PTCA is associated with less angina but more CABG in patients with nonacute CAD than is medical treatment (2001) (0)
Late thrombolysis improved survival only if given within 12 hours of onset of acute myocardial infarction symptoms (1994) (0)
MY APPROACH to the patient with left main disease. (2018) (0)
Younger women with acute MI had more in-hospital deaths than men of the same age (2000) (0)
Review: Sgarbossa scores 3 have low sensitivity and high specificity for predicting MI in left bundle branch block (2009) (0)
Primary angioplasty for acute myocardial infarction complicated by out of hospital cardiac arrest (1998) (0)
Curriculum in Cardiology Dronedarone and vitamin K antagonists: A review of drug-drug interactions Review Article (2010) (0)
Atherectomy led to a greater gain in lumen size than did balloon angioplasty but restenosis rates and clinical events did not differ at 6 months in coronary artery disease (1994) (0)
MICHIGAN DEPARTMENT OF COMMUNITY HEALTH CARDIAC CATHETERIZATION (CC) STANDARD ADVISORY COMMITTEE (SAC) MEETING (2007) (0)
Expanding indications for thrombolytic therapy in AMI (1989) (0)
Reply: Intravascular Imaging: Too Much or Too Little of a Good Thing? (2020) (0)
In patients with suspected AMI and LBBB, algorithms based on ECG and troponin data were tested to rule MI in or out (2019) (0)
Chapter 11 – ST-Elevation Myocardial Infarction (2007) (0)
What Is a Periprocedural Major Adverse Event After PCI and CABG? (2023) (0)
Meeting the Challenge of Tomely STEMI Transfer (2012) (0)
Vessel Overlap, Foreshortening, and Ostial Lesions (2010) (0)
Reassessing Patients Over Time : How To Follow Patients on Treatment (2009) (0)
Percutaneous Transluminal Coronary Angioplasty Improves Survival (2005) (0)
Bypass surgery and angioplasty were similarly effective in relieving angina (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Eric Randolph Bates?

Eric Randolph Bates is affiliated with the following schools:

Eric Randolph Bates's Academic­Influence.com Rankings

Eric Randolph Bates's Degrees

Why Is Eric Randolph Bates Influential?

Eric Randolph Bates's Published Works

Published Works

What Schools Are Affiliated With Eric Randolph Bates?

Eric Randolph Bates's AcademicInfluence.com Rankings